Not applicableStudy completedNCT05374928What this trial is testingHuman Epilepsy Project 3Who this might be right forIdiopathic Generalized Epilepsy NYU Langone Health 316
Not applicableActive Not RecruitingNCT03655223What this trial is testingEarly Check: Expanded Screening in NewbornsWho this might be right forSpinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more RTI International 30,000
Not applicableLooking for participantsNCT01793168What this trial is testingRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordWho this might be right forRare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more Sanford Health 20,000
Large-scale testing (Phase 3)Study completedNCT01393743What this trial is testingA Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic SeizuresWho this might be right forSeizure Disorder Generalized Tonic Clonic Eisai Inc. 163
Large-scale testing (Phase 3)Study completedNCT01747915What this trial is testingA Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.Who this might be right forGeneralized Tonic Clonic Seizures Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 219
Large-scale testing (Phase 3)Study completedNCT01463306What this trial is testingA 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic SeizuresWho this might be right forEpilepsy, Partial SeizuresEpilepsy, Primary Generalized Tonic-Clonic Seizures Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 605
Testing effectiveness (Phase 2)Study completedNCT01118962What this trial is testingOpen-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With EpilepsyWho this might be right forEpilepsy UCB BIOSCIENCES, Inc. 39
Large-scale testing (Phase 3)Study completedNCT02408549What this trial is testingSafety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic SeizuresWho this might be right forEpilepsy UCB BIOSCIENCES, Inc. 239
Not applicableStudy completedNCT01431326What this trial is testingPharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareWho this might be right forAdenovirusAnesthesiaAnxiety+56 more Daniel Benjamin 3,520
Not applicableWithdrawnNCT03254680What this trial is testingTurmeric as Treatment in EpilepsyWho this might be right forEpilepsyDravet SyndromeLennox-Gastaut Syndrome+2 more NYU Langone Health
Testing effectiveness (Phase 2)Looking for participantsNCT06908356What this trial is testingAn Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic SeizuresWho this might be right forFocal Onset SeizurePrimary Generalized Epilepsy Praxis Precision Medicines 50
Testing effectiveness (Phase 2)Study completedNCT05626634What this trial is testingOpen-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic EncephalopathyWho this might be right forDevelopmental and Epileptic EncephalopathyDravet SyndromeLennox-Gastaut Syndrome Longboard Pharmaceuticals 41
Large-scale testing (Phase 3)WithdrawnNCT00175851What this trial is testingOpen Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of EpilepsyWho this might be right forEpilepsy UCB Pharma
Not applicableStudy completedNCT01432821What this trial is testingBlinking and Yawning in Epilepsy: The Role of DopamineWho this might be right forIdiopathic Generalized Epilepsy Institut National de la Santé Et de la Recherche Médicale, France 31
Testing effectiveness (Phase 2)Study completedNCT05364021What this trial is testingStudy to Investigate LP352 in Subjects With Developmental and Epileptic EncephalopathiesWho this might be right forDevelopmental and Epileptic EncephalopathyDravet SyndromeLennox Gastaut Syndrome Longboard Pharmaceuticals 52
Not applicableActive Not RecruitingNCT05485831What this trial is testingEpidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALYWho this might be right forLennox Gastaut SyndromeDravet SyndromeTuberous Sclerosis Complex Jazz Pharmaceuticals 111
Testing effectiveness (Phase 2)Study completedNCT03650452What this trial is testingA Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic EncephalopathiesWho this might be right forEpilepsyDravet SyndromeLennox-Gastaut Syndrome Takeda 141
Testing effectiveness (Phase 2)Study completedNCT05972954What this trial is testingOMT-28 in Patients With Primary Mitochondrial Disease (PMD) (PMD-OPTION)Who this might be right forPrimary Mitochondrial Disease Omeicos Therapeutics GmbH 28
Not applicableLooking for participantsNCT06388174What this trial is testingIdiopathic Generalized Epilepsy SyndromesWho this might be right forEpilepsyEpilepsy, Idiopathic Generalized Shen Chun-Hong 200
Large-scale testing (Phase 3)Looking for participantsNCT05667142What this trial is testingEvaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic SeizuresWho this might be right forPrimary Generalized Tonic-Clonic Seizures Xenon Pharmaceuticals Inc. 160